Sophia Genetics

IPO

Democratizing Data-Driven Medicine, Together

Public · Lausanne, Switzerland · Founded 2011 · $245.8M raised

Headquarters
Lausanne
Employees
201–500
Founded
2011
Business Model
B2B
Total Funding
$245.8M
Last Round
$110.0M Series FOct 2020
Rounds
5
Type
Public

About

SOPHiA GENETICS operates the SOPHiA DDM™ platform, a technology-agnostic AI analytics system that computes, standardizes, and analyzes genomic, radiomic, and multimodal healthcare data. The platform serves hospitals, labs, and biopharma partners globally, enabling clinical-grade variant interpretation, liquid biopsy, and precision medicine workflows. It is IVDR-certified and supports applications across oncology, inherited disorders, and rare disease.

Summary

Sophia Genetics is an Artificial Intelligence company based in Lausanne, Switzerland, founded in 2011. It has raised $245.8M in total across 5 rounds, most recently a $110.0M Series F round in Oct 2020. Investors include aMoon, Generation Investment Management and Alychlo.

Tech & App Stack

6 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

IPOJul 2021
$234.0M

Sign up to see all 6 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies